Omni Voluntarily Modifies Inholtra Ads Following NAD Review
This article was originally published in The Tan Sheet
Executive Summary
Future ads for Omni Nutraceuticals' Inholtra Natural Pain Formula combination supplement will limit content comparisons to other glucosamine-containing products, the company agrees in NAD's recently released June Case Reports.